Do not miss the semi -annual sale of Tipranks
Eyenovia ((Eyen)) shared an ad.
On July 1, 2025, Hyperion DEFI, Inc. announced a brand change of the company EyenoviaInc., reflecting its new concentration on a cryptocurrency cash reserve strategy focused on the media threshing token. The actions of the company will be negotiated under the new symbol of Ticker “Hypd” on the NASDAQ from July 3, 2025. This strategic change is part of the vision of Hyperion DEFI to become a leader of the media threshing token and a pioneer of digital currency as a treasury. In addition, the company launched the validator of Kinetiq X Hyperion to improve its onchain engagement strategies.
The most recent analyst note on (Eyen) is a purchase with a price target of $ 560.00. To see the complete list of analyst forecasts on Eyenovia stock, see the Eyen Actions forecasting page.
SPARK set up on Eyen stocks
According to Spark, the IA analyst of Tipranks, Eyen is a sub-performance.
Eyenovia’s actions are strongly increased by poor financial performance, including significant operational losses and a low balance sheet. Although there is income growth, negative equity and insufficient production of cash flows are critical risks. Technical indicators also indicate a downward trend, and evaluation measures are not attractive due to a negative P / E ratio and the absence of dividends. These factors lead to a low global score.
To see the full report of Spark on the Eyen stock, Click here.
Learn more about Eyenovia
Hyperion Defi, Inc., formerly known as Eyenovia, Inc., is an American company listed on the pioneer in the development of ophthalmic technologies and the construction of a strategic treasure of native token of hyperliquid, media threshing. The company focuses on shareholders supply to the hyperliquid ecosystem and also develops the device filled with opta for ophthalmic applications.
Average trading volume: 4,433 994
Technical feeling signal: Sell
Current stock market cup: $ 30.44 million
For an in -depth examination of the Eyen stock, go to Tipranks overview page.
Warning and disclosure
